QMLGOct 9, 2019

A Dual-Hormone Closed-Loop Delivery System for Type 1 Diabetes Using Deep Reinforcement Learning

arXiv:1910.04059v112 citations
Originality Incremental advance
AI Analysis

This addresses the challenge of personalized glucose control for people with Type 1 Diabetes, though it is incremental as it builds on existing deep reinforcement learning techniques applied to a specific domain.

The researchers tackled the problem of automated hormone delivery for Type 1 Diabetes by developing a deep reinforcement learning system that uses dual hormones (insulin and glucagon) to manage blood glucose levels. The result was a strategy achieving 93% glucose time in target range for adults and 83% for adolescents in simulations, significantly outperforming previous methods.

We propose a dual-hormone delivery strategy by exploiting deep reinforcement learning (RL) for people with Type 1 Diabetes (T1D). Specifically, double dilated recurrent neural networks (RNN) are used to learn the hormone delivery strategy, trained by a variant of Q-learning, whose inputs are raw data of glucose \& meal carbohydrate and outputs are dual-hormone (insulin and glucagon) delivery. Without prior knowledge of the glucose-insulin metabolism, we run the method on the UVA/Padova simulator. Hundreds days of self-play are performed to obtain a generalized model, then importance sampling is adopted to customize the model for personal use. \emph{In-silico} the proposed strategy achieves glucose time in target range (TIR) $93\%$ for adults and $83\%$ for adolescents given standard bolus, outperforming previous approaches significantly. The results indicate that deep RL is effective in building personalized hormone delivery strategy for people with T1D.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes